Sulfonamide antimicrobial agents Flashcards
sulfonamide history
prontosil was active in vivo but inactive in vitro - never would’ve been discovered today
this is because it’s a prodrug
solfonamide MOA
In order to understand the mechanism of action of the sulfonamides, the biosynthesis of methylenetetrahydrofolate must be reviewed see notes
The incorporation of p-aminobenzoic acid (PABA) into the folic acid nucleus is inhibited competitively by the sulfonamides, which are bioisosteres of PABA. The sulfonamides inhibit dihydropteroate synthase. Since mammalian cells utilize preformed folates in the diet and some bacterial cells are required to make their own folic acid, the sulfonamides have selective toxicity for bacterial cells as opposed to mammalian cells.
A few strains of bacteria use sulfonamides as a substrate, but the product is not capable of undergoing the next reaction.
The antibiotic activity of sulfonamides can be reversed by adding large quantities of PABA to the diet.
structure activity relationships of sulfonamides
The structure of sulfanilamide resembles that of PABA, so it is not surprising that sulfanilamide is able to inhibit the incorporation of PABA into the folic acid nucleus. However, there is a significant difference in the acidity of PABA (pKa 6.5) vs. sulfanilamide (pKa 10.4). PABA is mainly anionic at physiological pH, whereas sulfanilamide is a weak acid (the ratio of anion:acid is 1:1000 at physiological 7.4).
Early work on the synthesis of sulfanilamide derivatives established that the attachment of electron-withdrawing heteroaromatic rings acidified the sulfonamide nitrogen and enhanced the potency. For example, the pKa of sulfisoxazole is 5. The increase in acidity is due to the electronegativity of the aromatic substituent as well as resonance stabilization of the anion.
The increase in acidity also decreases the incidence of crystalluria** (crystallization of the sulfonamide in the urine, resulting in kidney damage), although it is still recommended to drink large quantities of water with some sulfonamides in order to avoid crystalluria.
sulfonamide therapeutic uses
The following sulfonamides are used clinically: Sulfisoxazole, Sulfacetamide, Sulfabenzamide, Sulfadiazine, Acetyl Sulfisoxazole
(Deacetylated in GI tract), Sulfasalizine
Sulfisoxazole has broad spectrum** antibiotic activity and is currently the most popular sulfonamide. Sulfisoxazole and sulfamethoxazole are mainly used to treat simple urinary tract infections.
Sulfonamides in general inhibit both Gram-(+) and Gram-(–)** bacteria, nocardia, Chlamydia trachomatis, and some protozoa* and fungi*. Enteric bacteria such as E. coli, klebsiella, salmonella, shigella, and enterobacter, are inhibited.
Sulfonamides are usually used in combination. The resistance factors are too widespread** for these drugs to be used in a single drug therapy. The antifungal activity of trimethoprim-sulfamethoxazole
has become important for treatment of AIDS-infected patients that have developed infections caused by Pneumocystis carinii (changed to jiroveci). Trimethoprim inhibits dihydrofolate reductase, so the combination inhibits sequential steps in the biosynthesis of tetrahydrofolic acid.
Sulfisoxazole has broad spectrum antibiotic activity and is currently the most popular sulfonamide. Sulfisoxazole and sulfamethoxazole are mainly used to treat simple urinary tract infections.
Sulfasalazine is a prodrug that is not absorbed well from the GI tract. Bacteria in the GI tract metabolize it to sulfapyridine and 5-aminosalicylic acid, which has antiinflammatory activity. Sulfasalizine is used to treat ulcerative colitis and Crohn’s disease. Direct administration of salicylates, including 5-aminosalicylic acid, is irritating to the gastric mucosa. Note: Ulcerative colitis causes inflammation and ulcers in the top layer of the lining of the large intestine. In Crohn’s disease, all layers of the intestine may be involved.
Sulfadiazine in combination with pyrimethamine is used for first-line chemotherapy to treat acute toxoplasmosis. Toxoplasma gondii is similar to the pathogen that causes malaria, and infections are common and usually, but not always, subclinical.
sulfonamide adverse reactions
All sulfonamides and their derivatives are cross-allergenic**. Sulfonamide derivatives in use include carbonic anhydrase inhibitors (e.g. acetazolamide), thiazides (e.g. hydrochlorothiazide), furosemide, sulfonylurea hypoglycemic agents (e.g. tolbutamide), and others.
Allergic reactions are the most common and present as rash, photosensitivity, and drug fever. Stevens-Johnson syndrome is a rare skin and mucous membrane rash that is potentially fatal. Other adverse reactions include crystalluria and hematopoietic disturbances, including hemolytic or aplastic anemia, granulocytopenia, and thrombocytopenia.
Anorexia, nausea, vomiting occurs in 1%-2% of patients.
sulfonamide resistance
Resistance to sulfonamides occurs through the following mechanisms:
1) Mutations that cause overproduction of PABA
2) Mutations in the target enzyme (dihydropteroate synthase) that decrease its affinity for the sulfonamides
3) Mutations that result in a decrease in cell permeability to the sulfonamides
Note: resistance to sulfonamides is very common and this has largely eliminated their effectiveness as single-use agents. Resistance to combination therapy targeting two enzymes is highly reduced relative to mono-therapy, since to survive the microorganism would have to carry mutations in two enzymes.
Resistance to trimethoprim** is on the rise as indicated by a plasmid-borne copy of the dihydrofolate reductase (DHFR) gene. The DHFR gene often bears a mutation that enables the expressed enzyme to be active in the presence of drug through a decreased binding affinity of trimethoprim. BACTRIM is composed of 400 mg sulfamethoxazole (SMX) and 80 mg trimethoprim (TMP).
sulfonamide PKs
TMP is absorbed (85-90%) and distributed more rapidly than sulfonamides and dosages reflect this fact. Peak plasma levels are 2 µg/mL after 3 hours and the T1/2 is 10-12 hours. This drug and its inactive oxidized metabolites are cleared in the urine.
SMX is widely distributed in the body including the CSF and is also rapidly eliminated. It reaches peak serum levels of 30-60 µg/mL 3 hours after an oral dose of the combination therapy. The T1/2 is similar to TMP.
SMX is not as widely distributed as TMP because of the differences in lipophilicity. In tissue, the ratio of SMX/TMP is 1:2 to 1:5 indicating the preferential distribution of TMP to tissues relative to serum.
sulfoniamide metabolism
The sulfonamides are generally metabolized by N-4 N-acetylation and in some cases N-1 glucuronidation. The metabolites have no antibiotic activity. Hydroxylamine and nitroso metabolites are toxic.
Note: the human population can be divided into rapid and slow acetylators. This affects the rate of metabolism of sulfonamides in humans.
colistin
(polymyxin E) is a polymyxin antibiotic metabolite of Bacillus polymyxa. It is a nephrotoxic drug that is used as a last resort for treatment of multidrug-resistant Pseudomonas aeruginosa, Acinetobacter, and Klebsiella pneumoniae. Mechanism: colistin is a polycation that has lipophilic regions, so the overall structure resembles that of a cationic detergent that is able to solubilize bacterial membranes. It contains 5 unusual 2,4-diaminobutanoic acid residues that are protonated at physiological pH. The ammonium cations are able to displace cations in the bacterial cell membrane (Mg++ and Ca++) and facilitate binding of the antibiotic to anionic lipopolysaccharides in the cell membrane.
metronidazole
Metronidazole is useful for treatment of anaerobic bacteria and protozoa. It is the drug of choice for treatment of first episodes of mild to moderate C. difficile infections. Mechanism: partial reduction of the nitro group in anaerobic bacteria leads to a radical anion that degrades bacterial DNA. Since this happens only in anaerobic cells and not human cells, metronidazole has selective cytotoxicity for anaerobes.
disinfectant
a compound that kills the vegetative form of microorganisms, but not spores, on inanimate surfaces
sterilant
a compound that kills or removes all types of living microorganisms, including spores and viruses.
antiseptic
a compound that is applied to living tissue for the purpose of preventing infection.
alcohols MOA
Alcohols denature proteins.
Use of alcohols
Alcohols are used as antiseptics and disinfectants. The optimum bactericidal concentration is 60-90% by volume in water. They are not sterilants because they are not sporicidal. HIV is inactivated within 1 min by exposure to 70% ethanol or isopropanol. Note: absolute ethanol is less bactericidal than 60-90% ethanol because proteins are denatured more rapidly in the presence of water.